TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.37 
USD
Volume:  
1,633,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP WACC - Weighted Average Cost of Capital

The WACC of Tonix Pharmaceuticals Holding Corp (TNXP) is 7.5%.

The Cost of Equity of Tonix Pharmaceuticals Holding Corp (TNXP) is 11.35%.
The Cost of Debt of Tonix Pharmaceuticals Holding Corp (TNXP) is 5.00%.

Range Selected
Cost of equity 9.10% - 13.60% 11.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 8.6% 7.5%
WACC

TNXP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.13 1.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 13.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 8.6%
Selected WACC 7.5%